Cervical cancer brachytherapy registry study
Part of Cancer, Women’s health & pregnancy clinical trials.
This study collects information from patients with cervical cancer who are receiving standard treatment with chemotherapy, radiation, and brachytherapy (a type of internal radiation). The goal is to learn more about how this treatment works in a real-world setting to improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has spread locally but not to distant organs (stage IB to IVA).
- Your cancer type is squamous cell, adenocarcinoma, or adenosquamous carcinoma.
- You are planning to have a combination of chemotherapy, external radiation, and brachytherapy as your main treatment.
- Your cancer has not spread to other parts of the body (not metastatic).
- You have not had previous radiation for recurrent cervical cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the immune system responds to pelvic radiation therapy (with or without chemotherapy) in patients with cervical or other gynecologic cancers. It may help explain why some treatments work better and could lead to better treatments in the future.
This study looks at how well a type of internal radiation therapy called brachytherapy works for advanced cervical cancer. The treatment is given after chemotherapy and external radiation, and the study aims to see how effective and safe it is.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
This trial studies whether using CT scans to plan radiation treatment (brachytherapy) is as good as using MRI scans, for cervical cancer. If you join, you may receive standard radiation and chemotherapy, and the imaging method will be chosen randomly.
Hear when a new Stage IIIA Cervical Cancer FIGO 2018 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.